Growth Story Still Intact For TG Therapeutics Inc (TGTX)

TG Therapeutics Inc (TGTX) concluded trading on Wednesday at a closing price of $17.73, with 3.33 million shares of worth about $58.99 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 4.29% during that period and on June 26, 2024 the price saw a […]

TG Therapeutics Inc (NASDAQ: TGTX) Is Getting Increasingly Hard To Ignore

Currently, there are 146.39M common shares owned by the public and among those 136.40M shares have been available to trade. Insiders at the company have transacted a total of 10 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, […]

TG Therapeutics Inc (NASDAQ: TGTX): The Best-Of-Breed For Investing?

Currently, there are 146.39M common shares owned by the public and among those 136.40M shares have been available to trade. Insiders at the company have transacted a total of 10 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 7 of these insider trades were purchases, […]

TG Therapeutics Inc (NASDAQ: TGTX): Reassessing Prospects

TG Therapeutics Inc (TGTX) concluded trading on Wednesday at a closing price of $16.24, with 5.5 million shares of worth about $89.32 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 54.81% during that period and on Wednesday, January 31 the price saw a […]

Stick With TG Therapeutics Inc (TGTX). The Bull Are Alive And Well

The Vanguard Group, Inc. recently announced the acquisition of new stake in TG Therapeutics Inc (NASDAQ:TGTX). The institutional investor has increased its shareholding in the Healthcare company by 0.07% to 13.06 million shares with purchase of 9159.0 shares. This fresh investment now brings its stake to 8.63% valued currently at $223.14 million. In addition, SSgA […]

Handle With Care: TG Therapeutics Inc (NASDAQ: TGTX)

The Vanguard Group, Inc. recently announced the acquisition of new stake in TG Therapeutics Inc (NASDAQ:TGTX). The institutional investor has increased its shareholding in the Healthcare company by 0.07% to 13.06 million shares with purchase of 9159.0 shares. This fresh investment now brings its stake to 8.63% valued currently at $167.36 million. In addition, SSgA […]

Some Investing Thoughts On TG Therapeutics Inc (NASDAQ: TGTX)

TG Therapeutics Inc (TGTX) concluded trading on 01/03/24 at a closing price of $16.91, with 4.65 million shares of worth about $78.59 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -26.80% during that period and on Wednesday the price saw a loss of […]

TG Therapeutics Inc (NASDAQ: TGTX) Has Another Chance To Impress You

The Vanguard Group, Inc. recently announced the acquisition of new stake in TG Therapeutics Inc (NASDAQ:TGTX). The institutional investor has increased its shareholding in the Healthcare company by 0.07% to 13.06 million shares with purchase of 9159.0 shares. This fresh investment now brings its stake to 8.63% valued currently at $167.36 million. In addition, SSgA […]

TG Therapeutics Inc (NASDAQ: TGTX): Reassessing Prospects

The Vanguard Group, Inc. has recently announced that it has increased stake in TG Therapeutics Inc (NASDAQ:TGTX) by 0.07%. After grabbing 13.06 million shares, the institutional investor is now in possession of 9159.0 shares of the Healthcare Company. The new investment brought the stake of investor firm to 8.63% having worth around $167.36 million. Moreover, […]